{"pmid":32358882,"title":"Comment on \"Antipsoriatic treatments during COVID-19 outbreak\".","text":["Comment on \"Antipsoriatic treatments during COVID-19 outbreak\".","Dermatol Ther","Abdelmaksoud, Ayman","Goldust, Mohamad","Vestita, Michelangelo","32358882"],"journal":"Dermatol Ther","authors":["Abdelmaksoud, Ayman","Goldust, Mohamad","Vestita, Michelangelo"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358882","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/dth.13491","keywords":["covid-19","psoriasis","therapy"],"weight":0,"_version_":1666138495297519617,"score":9.490897,"similar":[{"pmid":32223073,"title":"Antipsoriatic treatments during COVID-19 outbreak.","text":["Antipsoriatic treatments during COVID-19 outbreak.","Dermatol Ther","Di Lernia, Vito","32223073"],"journal":"Dermatol Ther","authors":["Di Lernia, Vito"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32223073","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1111/dth.13345","topics":["Treatment"],"weight":1,"_version_":1666138490204585984,"score":63.009506},{"pmid":32314483,"title":"COVID-19 and psoriasis: Should we fear for patients treated with biologics?","text":["COVID-19 and psoriasis: Should we fear for patients treated with biologics?","The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision.","Dermatol Ther","Amerio, Paolo","Prignano, Francesca","Giuliani, Federica","Gualdi, Giulio","32314483"],"abstract":["The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision."],"journal":"Dermatol Ther","authors":["Amerio, Paolo","Prignano, Francesca","Giuliani, Federica","Gualdi, Giulio"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314483","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13434","keywords":["covid-19","sars","biologics","psoriasis","therapy"],"topics":["Treatment"],"weight":1,"_version_":1666138493540106240,"score":55.319183}]}